SEC Form 4 · accession 0001209191-16-114135
Viking Therapeutics, Inc. · VKTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew W Foehr
Director
Period of report
Apr 13, 2016
Accepted (ET)
Apr 13, 2016 · 6:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001607678
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.00001 | Apr 13, 2016 | P | 20,000 | $1.24 | A | 26,250 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants (Right to Buy) | $1.50 | Apr 13, 2016 | P | 20,000 | A | Apr 13, 2016 | Apr 13, 2021 | Common Stock | 20,000 | 20,000 | D |